Private equity firm buys ultrasound supplier.
Theft up 19 percent from last year.
For drugs used in the preparation of Tc-99m.
This month's roundup of the latest industry products.
Time is running out for Congress to take action.
Image intensifier market remains surprisingly stable.
Market expected to triple globally by 2018.
Current model can be misleading.
Product has multiple clinical benefits.
Whole-body scan shows clues in heart and brain.
Government busts imaging firm for kickbacks.
A new technology solution might help.
Bang for your buck: CT.
Health facilities seek primary care and non-physician practitioners.
Software may help reduce repeat scans and biopsies.
Siemens' Symbia Intevo aims to SPECT/CT.
Rule will reduce CT and MR reimbursements.
New analysis of health insurance exchange rates.
What's driving the comeback?
OPPS rules: Short-term boon for nuclear medicine or long-term gloom?
50% of equipment needs replacing.
Nuclear medicine aims to optimize dose, too.
Study estimates cost of top 5 infections.
Income disparity persists in health care, study finds.
More stringent screening criteria proposed to avoid low-risk thyroid nodules.
More bang for your buck: radiation therapy
More bang for your buck: X-ray tubes
Reeling from reimbursement cuts, the modality may have a new cash cow.
Therapeutic ultrasound heats up.
AATS endorses the Task Force's draft recommendation.
"Medicine isn't the problem, it's the business of medicine."
17% of medical providers will change EMRs this year.
Insurers are required to cover some screenings.
Evidence is emerging for more appropriate use of imaging.
Sometimes disaster preparedness is all talk.
The market prediction for 2021.
"Profitability in Japanese market is so much higher."
Reimbursement process for Lymphoseek to be streamlined.
PETNET will make a new beta-amyloid imaging agent.
Hospital-born infections' tough, high-tech new foes.
